Hostname: page-component-cd9895bd7-hc48f Total loading time: 0 Render date: 2024-12-27T21:16:54.266Z Has data issue: false hasContentIssue false

Layered Double Hydroxide-Based MRI/CT Dual Modal Contrasting Agent With Homogeneous Particle Size

Published online by Cambridge University Press:  01 January 2024

Sang-Yong Jung
Affiliation:
Department of Energy and Materials Engineering, Dongguk University-Seoul, Seoul, 04620, Republic of Korea
Jin Kuen Park*
Affiliation:
Department of Chemistry, Hankuk University of Foreign Studies, Yongin, 17035, Republic of Korea
Jae-Min Oh*
Affiliation:
Department of Energy and Materials Engineering, Dongguk University-Seoul, Seoul, 04620, Republic of Korea
*
*E-mail address of corresponding author: [email protected]
*E-mail address of corresponding author: [email protected]
Rights & Permissions [Opens in a new window]

Abstract

The development of nanoparticles incorporating Gd3+ has attracted interest in the field of contrasting nanomedicine for magnetic resonance (MR) and computed tomography (CT). In order to achieve an effective contrasting performance, the amount and stability of Gd incorporated as well as particle-size control of the nanoparticles should be considered simultaneously. In the current study, Gd-diethylenetriaminepentaacetate(Gd-DTPA) was incorporated into layered double hydroxide (LDH) to meet the physicochemical properties required for MR-CT dual contrasting nanomedicine. Strategically, the particle size and nanometer incorporation of Gd-DTPA into LDH (GL-R hybrid) were controlled homogeneously using the reverse micelle method. X-ray diffraction showed that the hybrid obtained possessed a hydrotalcite phase. Dynamic light scattering and electron microscopic analyses showed that the hybrid had a controlled size of <200 nm with significant homogeneity. Fast Fourier-transform of transmission electron microscopy confirmed that the platelets of the GL-R hybrids were oriented randomly to form inter-particle space, enabling the Gd-DTPA moiety to be encapsulated stably. The encapsulation efficiency of Gd-DTPA was 20.8%, which was sufficiently high compared with other Gd-DTPA-incorporatedLDH. According to X-ray photoelectron spectroscopy and Fourier-transform infrared spectroscopy, Gd-DTPA incorporated in the hybrid preserved its structure intact. Its potential as a dual modal contrast agent was demonstrated by measuring the concentration-dependent Hounsfield unit and magnetic resonance relaxivity, which were determined to be 230 at 2 mg/mL and 5.8 in the range ~0.2–1 mM-Gd, respectively.

Type
Article
Copyright
Copyright © Clay Minerals Society 2021

Introduction

Imaging-based diagnostic technologies such as magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), and single-positron emission computed tomography (SPECT) are utilized widely in clinical medicine (Wattjes et al., Reference Wattjes, Steenwijk and Stangel2015; Meng et al., Reference Meng, Cui, Bai, Yu, Xin, Fu, Wang, Du, Gao and Ye2019; Ma & Liu, Reference Ma and Liu2020; Zhang et al., Reference Zhang, Li, Wu, Yu, Song, Xiu and Shi2020). In order to obtain images with high resolution and accuracy in diagnosis, contrast agents (CA) are administered to patients. For example, iodinated contrast agents are utilized widely in CT imaging, especially to investigate dysfunction of the thyroid gland (Lusic & Grinstaff, Reference Lusic and Grinstaff2013); radionuclide F-18-tagged glucose is administered to diagnose various types of tumors at a systemic level, utilizing PET instruments (Alauddin, Reference Alauddin2012).

Recent advances in nanotechnology have improved the efficacy of CA and also addressed the disadvantages of molecular CA such as rapid clearance, unspecific systemic distribution, toxicity, etc. (Aime & Caravan, Reference Aime and Caravan2009; Vithanarachchi & Allen, Reference Vithanarachchi and Allen2012; Li et al., Reference Li, Jiang, Luo, Song, Lan, Wu and Gu2013a, Reference Li, Wang, Sun, Zhao, Lei, Lan, Cheng, Wang, Dou and Lu2013b). Various nanoplatforms are under development commercially and academically. Liposomal CT contrast agent is a well known example of commercialized nanotechnology based on CA in which iodinated phosphatidylcholine forms a liposomal bilayer with high iodine loading. Iron oxide nanoparticles are not just commercialized as an MRI contrasting agent but also studied academically in order to reinforce the functionalities (Li et al., Reference Li, Jiang, Luo, Song, Lan, Wu and Gu2013a). Due to the biocompatibility, significant X-ray attenuation ability, and easy surface modification, noble metals such as Au and Pt in nanoparticle form are attracting research interest for CT nanodiagnostics (Seltzer et al., Reference Seltzer, Shulkin, Adams, Davis, Hoey, Hopkins and Bosworth1984; Pedrosa & Baptista, Reference Pedrosa, Baptista, Rai and Kon2015; Xu et al., Reference Xu, Akakuru, Zheng and Wu2019).

Among various nanoplatforms, layered double hydroxide (LDH) has been highlighted due to its unique properties for biomedical application. The LDH is one of the family of layered materials, consisting of positively charged metal hydroxide layers and interlayer anions. The general chemical formula of LDH is represented as [M 2+1−x M 3+ x (OH)2] x+(A n x/n yH2O, where M 2+ and M 3+ represent divalent and trivalent cations to form the layer component and A n is an interlayer anion. LDH can accommodate safely various chemical species in the interlayer space (Choy, Reference Choy2004; Choy et al., Reference Choy, Kim, Son, Choy, Oh, Jung and Hwang2008; Kim et al., Reference Kim, Kim and Oh2012, Reference Kim, Ryu, Kang, Choi, Kim and Oh2013) and its solubility in weak acidic conditions can enable bioresorbability (Kriven et al., Reference Kriven, Kwak, Wallig and Choy2004) and biocompatibility (Choi et al., Reference Choi, Oh and Choy2010). Furthermore, size-controlled LDH exhibited high cellular uptake efficiency to cancer cells (Oh et al., Reference Oh, Park, Kim, Jung, Kang and Choy2006b, Reference Oh, Choi, Lee, Kim and Choy2009) and tumor targeting ability at the systemic level (Choi et al., Reference Choi, Oh and Choy2010). In this regard, extensive research has indicated the great potential of LDH as a drug or gene delivery carrier (Choy et al., Reference Choy, Kwak, Jeong and Park2000, Reference Choy, Jung, Oh, Park, Jeong, Kang and Han2004; Kim et al., Reference Kim, Lee, Kang, Kim, Kim and Oh2014). As the drug-delivery concept could be applied to contrasting agents, LDH is considered an alternative candidate for use as a CA nanoplatform.

Several scientific studies have dealt with nanodiagnostic applications of LDH such as manganese-based LDH for MRI (Li et al., Reference Li, Gu, Kurniawan, Chen and Xu2017; Xie et al., Reference Xie, Guo, Cao, Gao, Wang, Boyer, Kavallaris, Sun, Wang, Zhao and Gu2019), radioisotope-incorporated LDH for PET or SPECT (Musumeci et al., Reference Musumeci, Schiller, Xu, Minchin, Martin and Smith2010; Kim et al., Reference Kim, Lee, Kim, Park and Oh2016), and Gd-DTPA intercalated LDH for MRI, etc. (Xu et al., Reference Xu, Kurniawan, Bartlett and Lu2007; Kim et al., Reference Kim, Oh, Lee, Kim and Choy2008). Those pioneering studies suggested innovative ways not only to improve the performance of CA but also to provide CA with various functionalities. For the practical application of LDH-based nanodiagnostics, the next steps should focus on the following two points. (1) Nanodiagnostic CA with a small particle size and with narrow distribution in terms of biocompatibility and long-term circulation are required. Due to their anisotropic properties, LDH particles tend to agglomerate through strong edge-to-face interaction (Gursky et al., Reference Gursky, Blough, Luna, Gomez, Luevano and Gardner2006), hindering the preparation of small and homogeneous particle sizes in the hydrodynamic phase. (2) An alternative synthesis strategy to accommodate the contrasting moiety is necessary as previous approaches did not consider economic points such as the yield and loss of reactants.

In order to solve the above-mentioned challenges, a modified reverse-micelle method was adopted (Hu et al., Reference Hu, Wang, O'Hare and Davis2007). The method is considered to facilitate crystal growth of the LDH and incorporation of the contrasting moiety simultaneously in the confined space of the micelle. The particle growth and the degree of aggregation would be restricted, giving rise to a homogeneous reaction among precursors. In the current contribution, Gd-DTPA, an excellent molecule as an MRI-contrasting agent (Kim et al., Reference Kim, Oh, Lee, Kim and Choy2008) as well as a CT-contrasting agent (Bloem & Wondergem, Reference Bloem and Wondergem1989), was incorporated into LDH through a reverse micelle method to obtain an homogeneous and effective dual contrasting agent. The present authors hypothesized that the hybridization between Gd-DTPA and LDH would result in a particle with a concentrated Gd-DTPA moiety; in addition, the reverse-micelle method would prohibit unexpected growth of particles to enhance homogeneity of contrasting power. In order to control the hierarchical structure of hybrids, both coprecipitation and reconstruction method were applied respectively to prepared hybrids between Gd-DTPA and LDH. The influence of hierarchical structure and particle homogeneity of hybrids on dual contrasting power will be demonstrated below.

Experimental

Materials

Aluminum nitrate nonahydrate (Al(NO3)3·9H2O), hexadecyltrimethylammonium bromide (CH3(CH2)15N(Br)(CH3)3, CTAB), and diethylenetriaminepentaacetic acid gadolinium(III) dihydrogen salt hydrate (C14H20GdN3O10·xH2O, Gd-DTPA) were purchased from Sigma-Aldrich, Inc. (St. Louis, Missouri, USA). Magnesium nitrate hexahydrate (Mg(NO3)2·6H2O) was purchased from Junsei Chemical Co., Ltd. (Tokyo, Japan). Sodium hydroxide (NaOH), sodium bicarbonate (NaHCO3), and ethyl alcohol (C2H5OH, absolute grade) were obtained from Daejung Chemicals and Metal Co., Ltd. (Siheung, Korea). Acetone (C3H6O, extra pure grade) and 1-butanol (C4H10O, extra pure grade) were obtained from Samchun Pure Chemical Co., Ltd. (Seoul, Korea). Cyclohexane (C6H12, extra pure grade) was purchased from Duksan Company (Seoul, Korea).

Preparation of Gd-incorporated LDHs, GL-R, and GL-C

In order to prepare Gd-incorporated LDH hybrid with an homogeneous particle size (GL-R), the reverse micelle method was utilized referring to previous reports (Zhang et al., Reference Zhang, Ju, Wu, Liu, Hu, Xie and Zhang2001; Hu et al., Reference Hu, Wang, O'Hare and Davis2007). A microemulsion was prepared by adding 5 g of CTAB and 7.4 mL of 1-butanol to cyclohexane (200 mL). Three kinds of reaction solution – 2.07 mL of mixed metal solution (2.4 mol/L Mg2+ and 0.8 mol/L Al3+), 5 mL of Gd-DTPA solution (~0.48~0.5 mol/L), 3 mL of sodium hydroxide solution (0.02 mol/L) – were added successively to the microemulsion.

After stirring for 24 h at room temperature, the suspension was centrifuged and the surfactant was removed by the following process. First, the precipitate was redispersed in water:ethanol (1:1) at 75°C for 8 h. The precipitate was again collected by centrifugation and redispersed in acetone at 50°C for 8 h. Finally the precipitate obtained was dried at room temperature for 8 h.

For comparative study, GL without reverse micelle treatment was prepared by conventional coprecipitation (GL-C). With the same stoichiometry, three solutions – 2.07 mL of mixed metal solution (2.4 mol/L Mg(NO3)2·6H2O and 0.8 mol/L Al(NO3)3·9H2O), 5 mL of Gd-DTPA solution (~0.48~0.5 mol/L), 3 mL of sodium hydroxide solution (0.02 mol/L) – were mixed and stirred for 24 h under ambient conditions. The stoichiometry and concentration of reactants in the GL-C synthesis were controlled in the same way as those in the GL-R synthesis. Then, the precipitate was washed and dried as for GL-R.

Characterization

Powder X-ray diffraction (XRD) patterns (Bruker D2 PHASER, Billerica, Massachusetts, USA), using Ni-filtered CuKα radiation (λ = 1.5418 Å) with step sizes and time/step of 0.02°2θ and 0.2 s, respectively, were obtained to investigate the crystallite size and crystal structure of GL-R and GL-C. The particle morphology and distribution of GL-R and GL-C were observed by field emission scanning electron microscopy (FE-SEM, JEOL 7100F, Tokyo, Japan). For SEM measurements, 0.5 mg/mL of suspension prepared with GL-R and GL-C in ethanol was dispersed by tapping the suspension gently. Then the suspension was placed dropwise onto a Si wafer. High-resolution transmission electron microscopy (HR-TEM) and fast Fourier transform (FFT) using a Titan G2 ChemiSTEM Cs Probe of FEI company (Hillsboro, Oregon, USA) were used at an accelerating voltage of 200 kV. For TEM measurements, sample suspensions were placed on a Tedpella, Inc. (Redding, California, USA) 200 mesh Cu grid. The hydrodynamic radius was measured with an Otsuka electronics ELSZ-1000 (Osaka, Japan) instrument at a suspension concentration of 0.1 mg/mL. The accumulation and repetition times were 50 s and 3 s, respectively. Fourier-transform infrared (FTIR) attenuated total reflectance (ATR) spectroscopy (Perkin Elmer Spectrum 65, Perkin Elmer Co. Ltd., Waltham, Massachusetts, USA) was done in the powder state. X-ray photoelectron spectroscopy (XPS) was carried out using a Thermo K alpha+ instrument (Waltham, Massachusetts, USA) operating at a pressure of <5 × 10–8 mbar. AlKα radiation (1486.7 eV) at 50 eV pass energy (the energy with which all photoelectrons will enter the spectrometer) was applied and the scan resolution was 0.1 eV.

CT/MRI Test

To investigate the concentration-dependent Hounsfield unit (HU), a GL-R stock suspension was prepared in deionized water (2 mg/mL) and then diluted to 1, 0.8, 0.4, and 0.2 mg/mL. Then 200 μL of each diluted suspension and the stock suspension was put into each well of a 96 well plate after vortexing for 2 min. CT measurement was carried out with a Biograph mCT (Siemens Medical Solutions Inc., Munich, Germany) instrument operating at 120 kV, 35 mA, and with a 17.55 s scan time.

In order to assess the MRI contrasting efficiency of GL-R, a sample was dispersed in pH 7 phosphate-buffered saline to prepare a stock suspension with 1 mmol/L of Gd3+ ion concentration, which was then diluted to 0.8, 0.6, 0.4, and 0.2 mM. The longitudinal relaxation (T 1) time was measured at 1, 0.8, 0.6, 0.4, and 0.2 mmol/L with a Bruker 4.7 T MRI (Billerica, Massachusetts, USA), equipped with a 72 mm solenoid coil. MR images were acquired with flipped angle of 90°, TR/TE/NEX 100/7.8/1, FOV = 5.4 cm × 7.4 cm, data matrix 128 × 128, slice thickness 1 mm.

Results and Discussion

The Gd-complex-incorporated LDH with sufficient Gd content, small particle size, and homogeneous distribution (GL-R) was obtained by the reverse-micelle method (Fig. 1a). Although the coprecipitation method is well known and the easiest way to synthesize LDH, it has limitations in terms of size control and particle aggregation (Fig. 1b). The LDHs prepared by simple coprecipitation tend to agglomerate through strong edge-to-face interaction which is generally found in anisotropic clay materials (Gursky et al., Reference Gursky, Blough, Luna, Gomez, Luevano and Gardner2006). Taking into account the medical application of LDH through vascular injection, large agglomerates may cause problems such as lethal clogging in blood vessels. Furthermore, to incorporate a Gd-moiety in the hybrid easily, another strategy was needed. Generally, guest molecules are intercalated between LDH layers for stabilization and functionalization. A neatly intercalated phase is often difficult to obtain and the process requires a large amount of guest in order to achieve a concentration gradient. In the reverse-micelle method, the small LDH crystallites and Gd-DTPA molecules would be hybridized homogeneously through charge–charge interaction (positive layer charge of LDH-negative charge of DTPA ligand). As Gd-DTPA is well known as a T 1-MRI contrast agent and has an X-ray attenuating property suitable for a CT contrast agent, homogeneous GL-R prepared thus is considered to have multimodal contrasting ability.

Fig. 1 Schematic illustration of the synthesis strategy

The crystal structure of GL-C and GL-R was analyzed using XRD (Fig. 2). Diffraction peaks of GL-R were observed at 11.62, 23.14, 34.74, 39.23, 45.98, 60.61, and 61.84°2θ, corresponding to the crystal planes (003), (006), (012), (015), (018), (110), and (113), respectively, of hydrotalcite (JCPDS No.14-0191). Similarly, the XRD pattern of GL-C showed peaks at 11.37, 22.74, 34.41, 38.97, 45.32, 60.40, and 61.67°2θ for the hydrotalcite phase. The lattice parameters calculated from the peak positions (Table 1) suggested that Gd-incorporated LDH showed no significant differences in unit-cell dimension with respect to the synthesis method. Worth noting, however, is that the peak intensities were modestly different; diffraction peaks of GL-C were quite intense compared with GL-R for all the crystal planes. In order to estimate quantitatively the crystallinity along a certain plane, Scherrer’s equation was utilized as follows: t = (0.9λ)/(B·cosθ) where t = crystallite size, λ = X-ray wavelength, B = full-width-at-half-maximum, θ = Bragg angle. As shown in Table 1, the crystallite size of GL-R was 10.43 and 5.70 nm along the (110) and (003) planes, respectively; on the other hand, the crystallite sizes for GL-C were 12.93 and 14.46 nm for the (110) and (003) planes, respectively. In other words, GL-C had 1.24 times and 2.54 times more ordered arrangements along the (110) and (003) directions, respectively, than GL-R. As expected, the crystal growth of GL-R was restrained, producing thin, platy particles, whereas GL-C was composed mainly of thick particles (Fig. 1).

Fig. 2 XRD patterns of a GL-R and b GL-C

Table 1 Lattice parameters and crystallite size for GL-R and GL-C

Taking into account the systemic application of GL-R as a contrasting agent for CT and MRI, the recommendation is that the particle size be controlled at <200 nm to avoid unexpected blood-vessel clogging (Peters et al., Reference Peters, Veronesi, Calderón-Garcidueñas, Gehr, Chen, Geiser, Reed, Rothen-Rutishauser, Schürch and Schulz2006; Hoshyar et al., Reference Hoshyar, Gray, Han and Bao2016). In this regard, the hydrodynamic radii of GL-R and GL-C were measured by dynamic light scattering (DLS). GL-R showed a single peak at 67.2 nm, while GL-C showed multiple peaks centered at 841.2, 2,163, and beyond 10,000 nm (Fig. 3), meaning that: (1) the primary particle size of GL-C was larger than that of GL-R; and (2) particles of GL-R were dispersed homogeneously while GL-C were assembled to form large agglomerates. The Z-average of GL-R (105.95 ± 3.45 nm) was 20 times smaller than that of GL-C (2097.2 ± 394.70 nm), confirming the large aggregates in GL-C. The degree of homogeneous dispersion was represented quantitatively by the polydispersity index (PDI): 0.70 ± 0.13 and 0.19 ± 0.00 for GL-C and GL-R, respectively. According to the literature, a PDI value of <0.2 means a monodisperse system, while a value of >0.7 means a broad and polydispersive system (Ribeiro et al., Reference Ribeiro, Breitkreitz, Guilherme, da Silva, Couto, Castro, de Paula, Machado and de Paula2017; Danaei et al., Reference Danaei, Dehghankhold, Ataei, Hasanzadeh Davarani, Javanmard, Dokhani, Khorasani and Mozafari2018). The colloidal property of GL-R hybrid was monitored for 7 days. As shown in Fig. S2 and Table S1 (Supplementary Information), colloidal parameters such as Z-average, hydrodynamic radius, PDI value, etc. of GL-R hybrids did not change significantly over 7 days, suggesting that the colloidal stability was good. Thus, a highly monodisperse particle-size distribution of GL-R in aqueous conditions was corroborated by PDI values. As expected from Fig. 1, the reverse micelle system provided a confined space for crystal growth, and interparticle interaction throughout the system was, therefore, fairly restricted. Therefore, GL-R particles had less chance to encounter each other, resulting in the small particles and less agglomeration.

Fig. 3 Hydrodynamic radii of GL-R and GL-C

Electron microscopy was used to cross-confirm the particle-size distribution result obtained from DLS. The primary particles of the GL-R were distributed homogeneously without showing significant aggregates (Fig. 4a). The particle size of GL-R was <100 nm as depicted in the Fig. 4a inset image. Although the primary particle of GL-C(Fig. 4b) was <100 nm, most of the particles were assembled together to form clumps which were >5 μm.

Fig. 4 SEM images of a GL-R and b GL-C

Microscopic analyses based on TEM and FFT were carried out to investigate differences between GL-R and GL-C in terms of local crystal structure and morphology. Similar to the results obtained from DLS (Fig. 3) and SEM (Fig. 4), TEM also showed different degrees of dispersion in GL-R and GL-C. While GL-R showed small assemblages consisting of ~30 particles within the range ~100–150 nm (Fig. 5a), GL-C exhibited huge aggregations of >1 μm (Fig. 5d). High-resolution images showed lattice fringes of GL hybrids (Fig. 5b, e), which were attributed to the (015), (018), and (113) lattice planes (Fig. 5c, f). The lattice fringes were aligned in various directions (Fig. 5c,f), suggesting that the primary particles of LDHs were arranged randomly, possibly forming inter-particle cavities.

Fig. 5 a, d TEM images, b, ehigh-resolution images, and c, f FFT patterns for a–cGL-R and df GL-C

Several approaches have been attempted to intercalate Gd-DTPA in the interlayer space of LDH to serve as a potential MRI contrasting agent (Xu et al., Reference Xu, Kurniawan, Bartlett and Lu2007; Kim et al., Reference Kim, Oh, Lee, Kim and Choy2008; Sun Zhou et al., Reference Sun Zhou, Marzke, Peng, Szilágyi and Dey2019). Although intercalation of Gd-DTPA is the best way in terms of stabilization and molecular arrangement, it has several drawbacks. Usually, ion-exchange based intercalation requires a high concentration of guest molecule to achieve a sufficient concentration gradient. Furthermore, the molecular size of Gd-DTPA is larger than the interlayer volume provided by LDH. The molecular volume of Gd-DTPA calculated by its bulk density (1.13 g/cm3) is 800 Å3 with 2(–) charges. On the other hand, the Gd-DTPA-intercalated LDH can give <600 Å3 per 2(+) charges (25 Å2/(+) of unit cell area (Oh et al., Reference Oh, Kwak and Choy2006a) × 10 Å of interlayer distance (Kim et al., Reference Kim, Oh, Lee, Kim and Choy2008)). The interlayer of LDH, therefore, does not provide sufficient space for Gd-DTPA to be accommodated, resulting in the co-intercalation of small anions such as carbonate and nitrate (Xu et al., Reference Xu, Kurniawan, Bartlett and Lu2007; Kim et al., Reference Kim, Oh, Lee, Kim and Choy2008). Unlike previous approaches to intercalation, the current material incorporated Gd-DTPA in the inter-particle space of LDH, resulting in the facilitated accommodation of guest molecules.

This difference was shown by the greater encapsulation efficiency (EE; (Gd-DTPA incorporated into LDH)/(Gd-DTPA utilized in reaction). The chemical formula of GL-R determined by ICP-OES was Mg3.07Al1(OH)8(CO3 2–)0.37(Gd-DTPA)0.13 showing that Gd-DTPA loading was fairly efficient. The EE and loading capacity (LC) of the current study were 20.8 and 24.7%, respectively, when high Gd amount (Gd/Al =1) was utilized. On the other hand, previous reports on Gd-DTPA intercalation into MgAl-LDH by ion-exchange showed respective EE and LC values of 17.3 and 29.9%, respectively, for a Gd/Al ratio of 1 (Xu et al., Reference Xu, Kurniawan, Bartlett and Lu2007); another study on Gd-LDH showed EE and LC values of 33.0 and 33.9% at a Gd/Al ratio of 1.2 (Kim et al., Reference Kim, Oh, Lee, Kim and Choy2008). This means that when the same amount of Gd-DTPA is administered, the amount of Gd moiety which is incorporated into LDH is more efficient in GL-R than elsewhere. The encapsulation strategy of the current research could, therefore, accommodate sufficient Gd-DTPA with a small guest concentration.

The intact structure of Gd-DTPA in GL-R hybrid was identified by FTIR. The IR spectrum of Gd-DTPA showed typical absorption peaks of DTPA chelate at 1320 and 1092 cm–1 attributed to νs(C-N) and νs(C-O), respectively (Ionescu et al., Reference Ionescu, Li, Wiehl, Mera and Riedel2017). Only one peak was observed at 1360 cm–1 coming from CO3 2– vibrations in the spectrum of MgAl-LDH(Fig. 6c). The representative peaks from both Gd-DPTA(Fig. 6) and MgAl-LDH were also found in the IR spectrum of GL-R. The νs(C-N) vibration occurred as a humped peak having a small side shoulder due to the strong absorption of CO3 2–. This indicated that the Gd-DTPA moiety was well preserved in the GL-R hybrid. Furthermore, the νas(COO) and νsym(COO) of Gd-DTPA were found at 1571 and 1442 cm–1; those of GL-R were observed at comparable wavenumber positions. According to previous research, the difference between νas(COO) and νsym(COO), i.e. Δν, is related to the coordination mode and geometry of carboxylate (Deacon & Phillips, Reference Deacon and Phillips1980; Choy et al., Reference Choy, Kwon, Han, Song and Chang1998; Yang et al., Reference Yang, Han, Park, Park, Hwang and Choy2007). As the Δν of Gd-DTPA and GL-R was between 150 and 200 cm–1, the DTPA moiety in both samples is expected to be preserved in a unidentate chelating mode.

Fig. 6 FTIR spectra of a Gd-DTPA, b GL-R, and c MgAl-LDH

Because Gd-DTPA was incorporated in LDH under OH-rich conditions, Gd-DTPA may have hydrolyzed to form an unexpected complex. XPS analysis was, thus, carried out to investigate the chemical properties of Gd-DTPA after incorporation in the GL-R hybrid. The XPS spectrum of GL-R was compared with that of Gd-DPTA with respect to Gd 4d5/2 and Gd 4d3/2. The XPS spectrum of Gd-DTPA(Fig. 7a) showed peaks at 146.83 and 141.75 eV for Gd 4d3/2 and Gd 4d5/2, respectively (Pan et al., Reference Pan, Yang, Fang, Zheng, Song and Yi2017). The XPS profile of GL-R exhibited two peaks for Gd 4d3/2 and Gd 4d5/2 which were at binding energies of 146.66 and 141.93 eV, respectively, similar to those for Gd-DTPA. In Fig. 7b, the N 1s electron in GL-R had a binding energy of 398.71 eV, which was similar to the N 1s peak of Gd-DTPA (398.85 eV) attributed to a C–N bond in the DTPA chelate (Fig. 7b) (Zatsepin et al., Reference Zatsepin, Boukhvalov, Zatsepin, Kuznetsova, Mashkovtsev, Rychkov, Shur, Esin and Kurmaev2018). The result, in parallel with the FTIR study, suggested that GL-R contained, intact, the structure of Gd-DTPA in the hybrid. One of the possible Gd-complex impurities under the current synthesis conditions is the hydrolysis product, Gd(OH)3. The formation of Gd(OH)3 in the GL-R hybrid was excluded, however, because the Gd 4d3/2 peak at 147.6 eV, attributed to Gd(OH)3, was absent (Ullah et al., Reference Ullah, Imran, Liang, Yuan, Zeb, Jiang, Qazi, Sahar and Xu2017). The small peak at ~152.3 eV was attributed to ligand-to-metal charge transfer (Zatsepin et al., Reference Zatsepin, Boukhvalov, Zatsepin, Kuznetsova, Mashkovtsev, Rychkov, Shur, Esin and Kurmaev2018); at this stage, however, why a charge-transfer band developed in GL-R is unclear.

Fig. 7 XPS spectra of a Gd 4d and b N 1s for GL-R and Gd-DTPA

To check the CT contrasting ability of GL-R, concentration-dependent X-ray attenuation was performed (Fig. 8). In the concentration range of 0.2–2.0 mg/mL, GL-R showed HU values of between 190 and 230. As represented in the inset of Fig. 8, the HU values increased with concentration with a high regression coefficient of 0.9478. Considering that commercial iodinated CT contrast agent, OmnipaqueTM, shows 140 HU at 10 mg/mL(Li et al., Reference Li, Liu, Fu, Cheng, Liu, Yu, Wang, Wan and Yuan2019), the current GL-R is considered to have sufficiently high X-ray attenuation of ~190 HU even at the low concentration of 0.2 mg/mL. The HU value of LDH itself showed no significant concentration dependence (Fig. S1) and the values were no different from those of body organs. The Gd-DTPA moiety incorporated in the GL-R hybrid was, therefore, concluded to have played an important role in the CT contrasting property, and the Gd-DTPA was incorporated stably within the inter-particle space made by LDH nanoplates.

Fig. 8 CT values of GL-R

The dependence of GL-R as T 1-MRI CA on Gd3+ concentration was investigated (Fig. 9). As the concentration of the contrast moiety increased, the 1/T 1 value increased and the brightness of the MR image also increased linearly. Linear regression analysis between [Gd3+] and 1/T 1 showed high linearity with a regression coefficient of 0.9969. This kind of concentration dependence was expected, as a greater concentration would result in more contact with protons and, thus, enhance the contrast in the image (Caravan et al., Reference Caravan, Ellison, McMurry and Lauffer1999; Na et al., Reference Na, Jung, An, Park, Park, Lee, Nam, Kim, Kim, Kim, Lim, Kim, Kim and Hyeon2007). The T 1 relaxivity (r1) was measured to check the contrasting ability of GL-R in a T 1-weighted image. The r1 value of GL-R was determined to be 5.8, which was comparable with 3.87 of r1 of commercial Gd-DTPA, Magnevist® (Gao et al., Reference Gao, Zhou, Yu, Li, Liu and Sun2017).

Fig. 9 T 1 relaxivity plot and MR images of GL-R

Conclusions

A gadolinium complex, Gd-DTPA, was incorporated in the assembly of LDH platelets through the reverse-micelle method. Compared with coprecipitation, which usually produces large aggregations/agglomerations, the reverse-micelle method controlled efficiently the particle size of the Gd-DTPA/LDH hybrid, keeping it as small as possible with an homogeneous particle size of 150 nm. The hybrid particle maintained its monodispersity under hydrodynamic conditions, implying its biocompatibility at a systemic level. In TEM and FFT patterns, interparticle cavities were expected, resulting from the randomly arranged LDH nanoplatelets. Spectroscopic analyses, FTIR and XPS, confirmed that the Gd-DTPA moiety preserved its structure intact after incorporation in LDH. Chemical quantification revealed that the encapsulation efficiency of Gd-DTPA in the hybrid was fairly high despite small Gd/Al ratios of reactant. The possibility of the hybrid serving as a CT/MRI dual modal contrasting agent was checked by concentration-dependent HU and T 1 measurements, resulting in ~230 HU at 2 mg/mL and 5.8 of r1 relaxivity, respectively; the values were comparable with those of commercial, single-mode contrasting agents.

Supplementary Information

The online version contains supplementary material available at https://doi.org/10.1007/s42860-021-00142-9.

Acknowledgment

This research was supported by the Dongguk University Research Fund of 2019.

Funding

Funding sources are as stated in the Acknowledgment.

Declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Footnotes

The paper is based on a presentation made during the 4th Asian Clay Conference, Thailand, June 2020.

References

Aime, S., & Caravan, P. (2009). Biodistribution of gadolinium-based contrast agents, including gadolinium deposition. Journal of Magnetic Resonance Imaging, 30, 12591267.CrossRefGoogle ScholarPubMed
Alauddin, M. M. (2012). Positron emission tomography (PET) imaging with 18F-based radiotracers. American Journal of Nuclear Medicine and Molecular Imaging, 2, 5576.Google Scholar
Bloem, J. L., & Wondergem, J. (1989). Gd-DTPA as a contrast agent in CT. Radiology, 171, 578579.CrossRefGoogle ScholarPubMed
Caravan, P., Ellison, J. J., McMurry, T. J., & Lauffer, R. B. (1999). Gadolinium(III) chelates as MRI contrast agents: Structure, dynamics, and applications. Chemical Review, 99, 22932352.CrossRefGoogle ScholarPubMed
Choi, S. J., Oh, J. M., & Choy, J. H. (2010). Biocompatible nanoparticles intercalated with anticancer drug for target delivery: Pharmacokinetic and biodistribution study. Journal of Nanoscience and Nanotechnology, 10, 29132916.CrossRefGoogle ScholarPubMed
Choy, J.-H. (2004). Intercalative route to heterostructured nanohybrid. Journal of Physics and Chemistry of Solids, 65, 373383.CrossRefGoogle Scholar
Choy, J.-H., Jung, J.-S., Oh, J.-M., Park, M., Jeong, J., Kang, Y.-K., & Han, O.-J. (2004). Layered double hydroxide as an efficient drug reservoir for folate derivatives. Biomaterials, 25, 30593064.CrossRefGoogle ScholarPubMed
Choy, J.-H., Kim, Y.-K., Son, Y.-H., Choy, Y. B., Oh, J.-M., Jung, H., & Hwang, S.-J. (2008). Nanohybrids of edible dyes intercalated in znal layered double hydroxides. Journal of Physics and Chemistry of Solids, 69, 15471551.CrossRefGoogle Scholar
Choy, J.-H., Kwak, S.-Y., Jeong, Y.-J., & Park, J.-S. (2000). Inorganic layered double hydroxides as nonviral vectors. Angewandte Chemie International Edition, 39, 40414045.3.0.CO;2-C>CrossRefGoogle ScholarPubMed
Choy, J.-H., Kwon, Y.-M., Han, K.-S., Song, S.-W., & Chang, S. H. (1998). Intra- and inter-layer structures of layered hydroxy double salts, Ni1–xZn2x(OH)2(CH3CO2)2x · nH2O. Materials Letters, 34, 356363.CrossRefGoogle Scholar
Danaei, M., Dehghankhold, M., Ataei, S., Hasanzadeh Davarani, F., Javanmard, R., Dokhani, A., Khorasani, S., & Mozafari, M. R. (2018). Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics, 10, 57.CrossRefGoogle ScholarPubMed
Deacon, G. B., & Phillips, R. J. (1980). Relationships between the carbon-oxygen stretching frequencies of carboxylato complexes and the type of carboxylate coordination. Coordination Chemistry Reviews, 33, 227250.CrossRefGoogle Scholar
Gao, L., Zhou, J., Yu, J., Li, Q., Liu, X., Sun, L., et al. (2017). A novel Gd-DTPA-conjugated poly(l-γ-glutamyl-glutamine)-paclitaxel polymeric delivery system for tumor theranostics. Scientific Reports, 7, 3799.CrossRefGoogle ScholarPubMed
Gursky, J. A., Blough, S. D., Luna, C., Gomez, C., Luevano, A. N., & Gardner, E. A. (2006). Particle-particle interactions between layered double hydroxide nanoparticles. Journal of the American Chemical Society, 128, 83768377.CrossRefGoogle ScholarPubMed
Hoshyar, N., Gray, S., Han, H., & Bao, G. (2016). The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction. Nanomedicine (Lond), 11, 673692.CrossRefGoogle ScholarPubMed
Hu, G., Wang, N., O'Hare, D., & Davis, J. (2007). Synthesis of magnesium aluminium layered double hydroxides in reverse microemulsions. Journal of Materials Chemistry, 17, 22572266.CrossRefGoogle Scholar
Ionescu, E., Li, W., Wiehl, L., Mera, G., & Riedel, R. (2017). Synthesis of nanocrystalline Gd2O2NCN from a versatile single-source precursor. Zeitschrift für anorganische und allgemeine Chemie, 643, 16811691.CrossRefGoogle Scholar
Kim, H. J., Ryu, K., Kang, J. H., Choi, A. J., Kim, T. I., & Oh, J. M. (2013). Anticancer activity of ferulic acid-inorganic nanohybrids synthesized via two different hybridization routes, reconstruction and exfoliation-reassembly. Scientific World Journal, 2013, 421967.CrossRefGoogle ScholarPubMed
Kim, S. Y., Oh, J. M., Lee, J. S., Kim, T. J., & Choy, J. H. (2008). Gadolinium (III) diethylenetriamine pentaacetic acid/layered double hydroxide nanohybrid as novel T1-magnetic resonant nanoparticles. Journal of Nanoscience and Nanotechnology, 8, 51815184.CrossRefGoogle ScholarPubMed
Kim, T.-H., Kim, H., & Oh, J.-M. (2012). Interlayer structure of bioactive molecule, 2-aminoethanesulfonate, intercalated into calcium-containing layered double hydroxides. Journal of Nanoscience and Nanotechnology, 2012, article 21. https://doi.org/10.1155/2012/987938CrossRefGoogle Scholar
Kim, T.-H., Lee, G. J., Kang, J.-H., Kim, H.-J., Kim, T.-I., & Oh, J.-M. (2014). Anticancer drug-incorporated layered double hydroxide nanohybrids and their enhanced anticancer therapeutic efficacy in combination cancer treatment. BioMed Research International, 2014, 193401.Google ScholarPubMed
Kim, T.-H., Lee, J. Y., Kim, M.-K., Park, J. H., & Oh, J.-M. (2016). Radioisotope Co-57 incorporated layered double hydroxide nanoparticles as a cancer imaging agent. RSC Advances, 6, 4841548419.CrossRefGoogle Scholar
Kriven, W. M., Kwak, S.-Y., Wallig, M. A., & Choy, J.-H. (2004). Bio-resorbable nanoceramics for gene and drug delivery. MRS Bulletin, 29, 3337.CrossRefGoogle Scholar
Li, L., Jiang, W., Luo, K., Song, H., Lan, F., Wu, Y., & Gu, Z. (2013a). Superparamagnetic iron oxide nanoparticles as mri contrast agents for non-invasive stem cell labeling and tracking. Theranostics, 3, 595615.CrossRefGoogle ScholarPubMed
Li, Z., Wang, S. X., Sun, Q., Zhao, H. L., Lei, H., Lan, M. B., Cheng, Z. X., Wang, X. L., Dou, S. X., & Lu, G. Q. (2013b). Ultrasmall manganese ferrite nanoparticles as positive contrast agent for magnetic resonance imaging. Advanced Healthcare Materials, 2, 958964.CrossRefGoogle ScholarPubMed
Li, B., Gu, Z., Kurniawan, N., Chen, W., & Xu, Z. P. (2017). Manganese-based layered double hydroxide nanoparticles as a T(1) -mri contrast agent with ultrasensitive pH response and high relaxivity. Advanced Materials, 29, 1700373.CrossRefGoogle Scholar
Li, X., Liu, Y., Fu, F., Cheng, M., Liu, Y., Yu, L., Wang, W., Wan, Y., & Yuan, Z. (2019). Single nir laser-activated multifunctional nanoparticles for cascaded photothermal and oxygen-independent photodynamic therapy. Nano-Micro Letters, 11, 68.CrossRefGoogle ScholarPubMed
Lusic, H., & Grinstaff, M. W. (2013). X-ray-computed tomography contrast agents. Chemical Reviews, 113, 16411666.CrossRefGoogle ScholarPubMed
Ma, S., & Liu, Y. (2020). Diagnostic value of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in sublingual and submandibular salivary gland tumors. Molecular and Clinical Oncology, 13, 27.Google ScholarPubMed
Meng, D., Cui, X., Bai, C., Yu, Z., Xin, L., Fu, Y., Wang, S., Du, Y., Gao, Z., & Ye, Z. (2019). Application of low-concentration contrast agents and low-tube-voltage computed tomography to chest enhancement examinations: A multicenter prospective study. Science Progress, 103, 0036850419892193.Google ScholarPubMed
Musumeci, A., Schiller, T., Xu, Z., Minchin, R., Martin, D., & Smith, S. (2010). Synthesis and characterization of dual radiolabeled layered double hydroxide nanoparticles for use in in vitro and in vivo nanotoxicology studies. The Journal of Physical Chemistry C, 114(2), 734740.CrossRefGoogle Scholar
Na, H., Jung, L., An, K., Park, Y. I., Park, M., Lee, I., Nam, D.-H., Kim, S. T., Kim, S.-H., Kim, S.-W., Lim, K.-H., Kim, K., Kim, S.-O., & Hyeon, T. (2007). Development of at1 contrast agent for magnetic resonance imaging using mno nanoparticles. Angewandte Chemie (International ed. in English), 46, 53975401.CrossRefGoogle Scholar
Oh, J.-M., Kwak, S.-Y., & Choy, J.-H. (2006a). Intracrystalline structure of DNA molecules stabilized in the layered double hydroxide. Journal of Physics and Chemistry of Solids, 67, 10281031.CrossRefGoogle Scholar
Oh, J.-M., Park, M., Kim, S.-T., Jung, J.-Y., Kang, Y.-G., & Choy, J.-H. (2006b). Efficient delivery of anticancer drug MTX through MTX-LDH nanohybrid system. Journal of Physics and Chemistry of Solids, 67, 10241027.CrossRefGoogle Scholar
Oh, J. M., Choi, S. J., Lee, G. E., Kim, J. E., & Choy, J. H. (2009). Inorganic metal hydroxide nanoparticles for targeted cellular uptake through clathrin-mediated endocytosis. Chemistry: An Asian Journal, 4, 6773.Google ScholarPubMed
Pan, Y., Yang, J., Fang, Y., Zheng, J., Song, R., & Yi, C. (2017). One-pot synthesis of gadolinium-doped carbon quantum dots for high-performance multimodal bioimaging. Journal of Materials Chemistry B, 5, 92101.CrossRefGoogle ScholarPubMed
Pedrosa, P., & Baptista, P. V. (2015). Chapter 1 - gold and silver nanoparticles for diagnostics of infection. In Rai, M. & Kon, K. (Eds.), Nanotechnology in diagnosis, treatment and prophylaxis of infectious diseases (pp. 118). Academic Press.Google Scholar
Peters, A., Veronesi, B., Calderón-Garcidueñas, L., Gehr, P., Chen, L. C., Geiser, M., Reed, W., Rothen-Rutishauser, B., Schürch, S., & Schulz, H. (2006). Translocation and potential neurological effects of fine and ultrafine particles a critical update. Particle and Fibre Toxicology, 3, 13.CrossRefGoogle ScholarPubMed
Ribeiro, L. N. M., Breitkreitz, M. C., Guilherme, V. A., da Silva, G. H. R., Couto, V. M., Castro, S. R., de Paula, B. O., Machado, D., & de Paula, E. (2017). Natural lipids-based nlc containing lidocaine: From pre-formulation to in vivo studies. European Journal of Pharmaceutical Sciences, 106, 102112.CrossRefGoogle ScholarPubMed
Seltzer, S. E., Shulkin, P. M., Adams, D. F., Davis, M. A., Hoey, G. B., Hopkins, R. M., & Bosworth, M. E. (1984). Usefulness of liposomes carrying losefamate for CT opacification of liver and spleen. American Journal of Roentgenology, 143, 575579.CrossRefGoogle ScholarPubMed
Sun Zhou, X.D., Marzke, R., Peng, Z., Szilágyi, I., & Dey, S.K. (2019). Understanding the high longitudinal relaxivity of Gd(DPTA)-intercalated (Zn,Al)-layered double hydroxide nanoparticles. Inorganic Chemistry, 58, 1211212121.CrossRefGoogle Scholar
Ullah, N., Imran, M., Liang, K., Yuan, C.-Z., Zeb, A., Jiang, N., Qazi, U., Sahar, S., & Xu, A.-W. (2017). Highly dispersed ultra-small pd nanoparticles on gadolinium hydroxide nanorods for efficient hydrogenation reactions. Nanoscale, 9, 1380013807.CrossRefGoogle ScholarPubMed
Vithanarachchi, S. M., & Allen, M. J. (2012). Strategies for targetspecific contrast agents for magnetic resonance imaging. Current molecular imaging, 1, 1225.CrossRefGoogle ScholarPubMed
Wattjes, M. P., Steenwijk, M. D., & Stangel, M. (2015). Mri in the diagnosis and monitoring of multiple sclerosis: An update. Clinical Neuroradiology, 25, 157165.CrossRefGoogle ScholarPubMed
Xie, W., Guo, Z., Cao, Z., Gao, Q., Wang, D., Boyer, C., Kavallaris, M., Sun, X., Wang, X., Zhao, L., & Gu, Z. (2019). Manganese-based magnetic layered double hydroxide nanoparticle: A pH-sensitive and concurrently enhanced T1/T2-weighteddual-mode magnetic resonance imaging contrast agent. ACS Biomaterials Science & Engineering, 5, 25552562.CrossRefGoogle ScholarPubMed
Xu, C., Akakuru, O. U., Zheng, J., & Wu, A. (2019). Applications of iron oxide-based magnetic nanoparticles in the diagnosis and treatment of bacterial infections. Frontiers in Bioengineering and Biotechnology, 7, 141141.CrossRefGoogle ScholarPubMed
Xu, Z. P., Kurniawan, N. D., Bartlett, P. F., & Lu, G. Q. (2007). Enhancement of relaxivity rates of Gd-dtpa complexes by intercalation into layered double hydroxide nanoparticles. Chemistry – A European Journal, 13, 28242830.CrossRefGoogle ScholarPubMed
Yang, J.-H., Han, Y.-S., Park, M., Park, T., Hwang, S.-J., & Choy, J.-H. (2007). New inorganic-based drug delivery system of indole-3-aceticacid-layered metal hydroxide nanohybrids with controlled release rate. Chemistry of Materials, 19, 26792685.CrossRefGoogle Scholar
Zatsepin, D. A., Boukhvalov, D. W., Zatsepin, A. F., Kuznetsova, Y. A., Mashkovtsev, M. A., Rychkov, V. N., Shur, V. Y., Esin, A. A., & Kurmaev, E. Z. (2018). Electronic structure, charge transfer, and intrinsic luminescence of gadolinium oxide nanoparticles: Experiment and theory. Applied Surface Science, 436, 697707.CrossRefGoogle Scholar
Zhang, J., Ju, X., Wu, Z. Y., Liu, T., Hu, T. D., Xie, Y. N., & Zhang, Z. L. (2001). Structural characteristics of cerium oxide nanocrystals prepared by the microemulsion method. Chemistry of Materials, 13, 41924197.CrossRefGoogle Scholar
Zhang, Y., Li, B., Wu, B., Yu, H., Song, J., Xiu, Y., & Shi, H. (2020). Diagnostic performance of whole-body bone scintigraphy in combination with spect/ct for detection of bone metastases. Annals of Nuclear Medicine, 34, 549558.CrossRefGoogle ScholarPubMed
Figure 0

Fig. 1 Schematic illustration of the synthesis strategy

Figure 1

Fig. 2 XRD patterns of a GL-R and b GL-C

Figure 2

Table 1 Lattice parameters and crystallite size for GL-R and GL-C

Figure 3

Fig. 3 Hydrodynamic radii of GL-R and GL-C

Figure 4

Fig. 4 SEM images of a GL-R and b GL-C

Figure 5

Fig. 5 a, d TEM images, b, ehigh-resolution images, and c, f FFT patterns for a–cGL-R and df GL-C

Figure 6

Fig. 6 FTIR spectra of a Gd-DTPA, b GL-R, and c MgAl-LDH

Figure 7

Fig. 7 XPS spectra of a Gd 4d and b N 1s for GL-R and Gd-DTPA

Figure 8

Fig. 8 CT values of GL-R

Figure 9

Fig. 9 T1 relaxivity plot and MR images of GL-R

Supplementary material: File

Jung et al. supplementary material
Download undefined(File)
File 63.8 KB